|
PUS7L expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.260600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.031800E-01 |
| Normal-vs-Stage2 |
9.293800E-01 |
| Normal-vs-Stage3 |
1.902190E-01 |
| Normal-vs-Stage4 |
7.253900E-02 |
| Stage1-vs-Stage2 |
5.812800E-01 |
| Stage1-vs-Stage3 |
3.815800E-01 |
| Stage1-vs-Stage4 |
1.362580E-01 |
| Stage2-vs-Stage3 |
3.012800E-01 |
| Stage2-vs-Stage4 |
1.684210E-01 |
| Stage3-vs-Stage4 |
6.791200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.575600E-01 |
| Normal-vs-AfricanAmerican |
6.39339999999322E-05 |
| Normal-vs-Asian |
8.679400E-01 |
| Caucasian-vs-AfricanAmerican |
4.34690000000737E-05 |
| Caucasian-vs-Asian |
7.404200E-01 |
| AfricanAmerican-vs-Asian |
4.102300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.773200E-01 |
| Normal-vs-Female |
8.542500E-02 |
| Male-vs-Female |
1.420850E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.769900E-02 |
| Normal-vs-Age(41-60Yrs) |
4.722200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.124400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.278400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.398020E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.931600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.130600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.298800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.592600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.331600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.293400E-01 |
| Normal-vs-Grade 2 |
7.208600E-01 |
| Normal-vs-Grade 3 |
1.900040E-01 |
| Normal-vs-Grade 4 |
1.592130E-02 |
| Grade 1-vs-Grade 2 |
7.477400E-01 |
| Grade 1-vs-Grade 3 |
8.726400E-01 |
| Grade 1-vs-Grade 4 |
3.640200E-01 |
| Grade 2-vs-Grade 3 |
3.044200E-01 |
| Grade 2-vs-Grade 4 |
2.395900E-02 |
| Grade 3-vs-Grade 4 |
1.236210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.750200E-01 |
| Normal-vs-ccB subtype |
7.441800E-01 |
| ccA subtype-vs-ccB subtype |
7.357000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.640000E-01 |
| Normal-vs-N1 |
9.023400E-01 |
| N0-vs-N1 |
9.485400E-01 |
|
|
